THURSDAY, Aug. 16, 2018 -- Ibalizumab has antiviral activity among patients with multidrug resistant (MDR) HIV-1 infection, according to a study published in the Aug. 16 issue of the New England Journal of Medicine. Brinda Emu, M.D., from the Yale...
Original Article: Ibalizumab Active in Multidrug Resistant HIV-1 Infection